Related Experiment Video
Updated: May 12, 2026

08:59
Defining Substrate Specificities for Lipase and Phospholipase Candidates
Published on: November 23, 2016
Dual substrate specificity of Bacillus subtilis PBP4a
Venkatesh V Nemmara1, S A Adediran, Kinjal Dave
1Department of Chemistry, Wesleyan University, Lawn Avenue, Middletown, Connecticut 06459, USA.
Biochemistry
|April 9, 2013
Summary
Researchers investigated bacterial dd-peptidases, finding Bacillus subtilis PBP4a has dual specificity for carboxylate and carboxamide substrates. This discovery offers potential for developing new antibiotics targeting bacterial cell walls.
Area of Science:
- Biochemistry and Molecular Biology
- Microbiology
- Drug Discovery
Background:
- Bacterial dd-peptidases are crucial targets for β-lactam antibiotics, but rising resistance necessitates novel non-β-lactam alternatives.
- Understanding dd-peptidase substrate specificity is key for designing new antibiotics, yet specific substrates for many enzymes remain unknown.
- Low-molecular mass (LMM) class B and C dd-peptidases typically recognize peptidoglycan N-termini, but variations exist, such as amidation in Bacillus subtilis.
Purpose of the Study:
- To investigate the substrate specificity of Bacillus subtilis PBP4a, specifically its ability to process carboxylate versus carboxamide termini.
- To compare the specificity of B. subtilis PBP4a with the Actinomadura R39 dd-peptidase, which lacks peptidoglycan amidation.
Main Methods:
- Enzymatic assays were performed using B. subtilis PBP4a and Actinomadura R39 dd-peptidase with various peptide substrates.
- Kinetic data were analyzed to determine substrate preferences at both acyl donor and acceptor sites.
- Crystal structures were examined, complemented by molecular modeling, to elucidate the structural basis for observed specificity differences.
Main Results:
- Bacillus subtilis PBP4a demonstrated dual specificity, accepting both carboxylate and carboxamide termini in peptide substrates.
- In contrast, the R39 dd-peptidase showed a strong preference for terminal carboxylates.
- Structural analysis revealed that a histidine residue at position 351 in PBP4a (compared to arginine in R39) likely accounts for its expanded substrate specificity.
Conclusions:
- The dual specificity of B. subtilis PBP4a, attributed to a key histidine residue, highlights a divergence in dd-peptidase evolution.
- This finding provides a basis for designing novel antibiotics that exploit the specific peptidoglycan structures of target bacteria.
- Targeting bacterial cell wall synthesis via specific dd-peptidase inhibition remains a viable strategy for combating antibiotic resistance.
Related Concept Videos
Bacterial RNA Polymerase
Unlike eukaryotes, bacteria use a single RNA Polymerase (RNAP) to transcribe all genes. The different subunits of bacterial RNAPhave distinct functions. The multisubunit structure of the bacterial RNAP helps the enzyme to maintain catalytic function, facilitate assembly, interact with DNA and RNA, and self-regulate its activity.
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...

